Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
Year: 2016
Type: article
Abstract: Adverse event CKDChronic kidney disease eGFR Estimated glomerular filtration rate SGLT2 Sodium-glucose co-transporter 2 UACR Urinary albumin/creatinine ratio
Source: Diabetologia
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,490
Funder: AstraZeneca
OpenAlex ID: W2436309489
